Genmab — Marts 2022
-
A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab https://onlinelibrary.wiley.com/doi/abs/10.1111/petr.14263
-
only for the Dutch... https://www.youtube.com/watch?v=72x_hg-vqDI
-
Aktier/Rusland: Derfor er den danske aktieudvikling ekstremt https://proinvestor.com/boards/101752
-
USA/åbning: Behersket fald fra start - boligindretningskæde markant op https://proinvestor.com/investornyt/791625/usa-abning-behersket-fald-fra-start-boligindretningskaede-markant-op
-
JNJ forventer hexa-38 data i år https://seekingalpha.com/article/4493464-johnson-and-johnson-jnj-management-42nd-annual-cowen-health-care-conference-transcript
-
Så teclistamab er modtaget som både breakthrough therapy designation & priority review af FDA. Det lugter af en godkendelse i H2
-
God morgen.
-
Aktier: Kun få C25 selskaber har ramt 2020 lavpunktet https://proinvestor.com/boards/101775
-
Hold da op, man skulle tro soldaterne havde lagt deres våben hvis man ser på kurserne
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind